Carr A - Search Results

1

Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injection.

Kelleher AD, Emery S, Cunningham P, Duncombe C, Carr A, Golding H, Forde S, Hudson J, Roggensack M, Forrest BD, Cooper DA. Kelleher AD, et al. Among authors: carr a. AIDS Res Hum Retroviruses. 1997 Jan 1;13(1):29-32. doi: 10.1089/aid.1997.13.29. AIDS Res Hum Retroviruses. 1997. PMID: 8989424 Clinical Trial.

2

Pathogenesis and management of HIV-associated drug hypersensitivity.

Carr A, Cooper DA. Carr A, et al. AIDS Clin Rev. 1995-1996:65-97. AIDS Clin Rev. 1995. PMID: 7488561 Review. No abstract available.

3

Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients.

Carr A, Penny R, Cooper DA. Carr A, et al. AIDS. 1993 Jan;7(1):65-71. doi: 10.1097/00002030-199301000-00010. AIDS. 1993. PMID: 8442919

4

Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group.

Ashton LJ, Carr A, Cunningham PH, Roggensack M, McLean K, Law M, Robertson M, Cooper DA, Kaldor JM. Ashton LJ, et al. Among authors: carr a. AIDS Res Hum Retroviruses. 1998 Jan 20;14(2):117-21. doi: 10.1089/aid.1998.14.117. AIDS Res Hum Retroviruses. 1998. PMID: 9462921

5

Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.

Carr A, Tindall B, Penny R, Cooper DA. Carr A, et al. AIDS. 1992 Feb;6(2):165-71. doi: 10.1097/00002030-199202000-00004. AIDS. 1992. PMID: 1558714

6

Prophylaxis of opportunistic infections in patients with HIV infection.

Carr A, Penny R, Cooper DA. Carr A, et al. J Acquir Immune Defic Syndr (1988). 1993;6 Suppl 1:S56-60. J Acquir Immune Defic Syndr (1988). 1993. PMID: 8426303 Review.

7

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir.

Kelleher AD, Carr A, Zaunders J, Cooper DA. Kelleher AD, et al. Among authors: carr a. J Infect Dis. 1996 Feb;173(2):321-9. doi: 10.1093/infdis/173.2.321. J Infect Dis. 1996. PMID: 8568292 Clinical Trial.

8

Current clinical experience with nevirapine for HIV infection.

Carr A, Cooper DA. Carr A, et al. Adv Exp Med Biol. 1996;394:299-304. doi: 10.1007/978-1-4757-9209-6_27. Adv Exp Med Biol. 1996. PMID: 8815694 Review.

9

HIV protease inhibitors.

Carr A, Cooper DA. Carr A, et al. AIDS. 1996;10 Suppl A:S151-7. doi: 10.1097/00002030-199601001-00021. AIDS. 1996. PMID: 8883623 Review. No abstract available.

10

CD8+ lymphocyte responses to antiretroviral therapy of HIV infection.

Carr A, Emery S, Kelleher A, Law M, Cooper DA. Carr A, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 1;13(4):320-6. doi: 10.1097/00042560-199612010-00004. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8948369 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,547 results

Search Page

Filters